Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.96 USD | -2.89% |
|
+35.01% | +235.83% |
15/07 | Second malaria vaccine launched in Ivory Coast in new milestone | RE |
02/07 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+235.83% | 2.31B | |
+25.13% | 47.96B | |
+2.16% | 42.45B | |
+44.19% | 41.47B | |
+27.46% | 31.6B | |
+21.53% | 28.63B | |
-6.35% | 28.03B | |
+52.24% | 14.56B | |
+47.30% | 14.14B | |
+4.08% | 12.58B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Transcript : Novavax, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 05